Squarepoint Ops LLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1642575 NEW YORK, NY

Position in LGND

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$7,206,852

+$5,930,290 QoQ

Shares Held

22,800

+256.6% QoQ

Ownership

0.114%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#90

of 415 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. LGND ranks #39 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	198,567	$123,814,467
2	BBIO	BridgeBio Pharma, Inc.	1,191,732	$88,760,199
3	ALNY	Alnylam Pharmaceuticals, Inc.	233,999	$70,440,718
4	INSM	INSMED Inc	616,464	$65,727,391
5	ARGX	Argenx SE	58,400	$54,181,768
6	RYTM	Rhythm Pharmaceuticals, Inc.	422,921	$46,956,918
7	APGE	Apogee Therapeutics, Inc.	290,713	$38,586,336
8	AXSM	Axsome Therapeutics, Inc.	154,605	$37,842,665

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,206,852	22,800	+256.6%	Shares	Defined	2026-08-14
2026-03-31	$1,276,562	6,394	-64.3%	Shares	Defined	2026-05-15
2025-09-30	$3,170,274	17,897	+412.2%	Shares	Defined	2025-11-14
2025-03-31	$367,359	3,494	-79.2%	Shares	Defined	2025-08-27
2024-12-31	$1,800,012	16,799	+449.3%	Shares	Defined	2025-02-14
2022-12-31	$204,274	3,058	-74.2%	Shares	Defined	2023-02-14
2022-09-30	$1,018,939	11,833	+50.4%	Shares	Defined	2022-11-14
2022-03-31	$884,846	7,866	+501.8%	Shares	Defined	2022-05-16
2021-12-31	$201,879	1,307	-70.2%	Shares	Defined	2022-02-14
2021-09-30	$610,360	4,381	-4.5%	Shares	Defined	2021-11-15
2021-03-31	$699,592	4,589	+26.8%	Shares	Defined	2021-05-17
2020-12-31	$359,909	3,619	-63.5%	Shares	Defined	2021-02-16
2020-09-30	$945,097	9,915	+4.2%	Shares	Defined	2020-11-16
2020-06-30	$1,064,476	9,517	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.